Paul R Kirchgraber - Net Worth and Insider Trading
Paul R Kirchgraber Net Worth
The estimated net worth of Paul R Kirchgraber is at least $3 Million dollars as of 2024-04-28. Paul R Kirchgraber is the CEO, Covance Drug Development of Laboratory Corp of America Holdings and owns about 12,946 shares of Laboratory Corp of America Holdings (LH) stock worth over $3 Million. Details can be seen in Paul R Kirchgraber's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul R Kirchgraber has not made any transactions after 2023-05-19 and currently still holds the listed stock(s).
Transaction Summary of Paul R Kirchgraber
Paul R Kirchgraber Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul R Kirchgraber owns 1 companies in total, including Laboratory Corp of America Holdings (LH) .
Click here to see the complete history of Paul R Kirchgraber’s form 4 insider trades.
Insider Ownership Summary of Paul R Kirchgraber
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
LH | Laboratory Corp of America Holdings | 2023-05-19 | CEO & Covance Drug Development |
Paul R Kirchgraber Latest Holdings Summary
Paul R Kirchgraber currently owns a total of 1 stock. Paul R Kirchgraber owns 12,946 shares of Laboratory Corp of America Holdings (LH) as of May 19, 2023, with a value of $3 Million.
Latest Holdings of Paul R Kirchgraber
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LH | Laboratory Corp of America Holdings | 2023-05-19 | 12,946 | 198.40 | 2,568,486 |
Holding Weightings of Paul R Kirchgraber
Paul R Kirchgraber Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul R Kirchgraber has made a total of 3 transactions in Laboratory Corp of America Holdings (LH) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Laboratory Corp of America Holdings is the sale of 4,300 shares on May 19, 2023, which brought Paul R Kirchgraber around $932,713.
Insider Trading History of Paul R Kirchgraber
- 1
Paul R Kirchgraber Trading Performance
Paul R Kirchgraber Ownership Network
Ownership Network List of Paul R Kirchgraber
Ownership Network Relation of Paul R Kirchgraber
Paul R Kirchgraber Owned Company Details
What does Laboratory Corp of America Holdings do?
Who are the key executives at Laboratory Corp of America Holdings?
Paul R Kirchgraber is the CEO & Covance Drug Development of Laboratory Corp of America Holdings. Other key executives at Laboratory Corp of America Holdings include EVP & Chief Marketing Officer Amy B. Summy , EVP & President-Diagnostics Lab Mark S Schroeder , and SVP & Global General Counsel Van Der Vaart Sandra D .
Laboratory Corp of America Holdings (LH) Insider Trades Summary
Over the past 18 months, Paul R Kirchgraber made 1 insider transaction in Laboratory Corp of America Holdings (LH) with a net sale of 4,300. Other recent insider transactions involving Laboratory Corp of America Holdings (LH) include a net sale of 15,183 shares made by Mark S Schroeder , a net sale of 4,846 shares made by Van Der Vaart Sandra D , and a net sale of 3,727 shares made by Amy B. Summy .
In summary, during the past 3 months, insiders sold 19,494 shares of Laboratory Corp of America Holdings (LH) in total and bought 0 shares, with a net sale of 19,494 shares. During the past 18 months, 34,440 shares of Laboratory Corp of America Holdings (LH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 34,440 shares.
Laboratory Corp of America Holdings (LH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Laboratory Corp of America Holdings Insider Transactions
Paul R Kirchgraber Mailing Address
Above is the net worth, insider trading, and ownership report for Paul R Kirchgraber. You might contact Paul R Kirchgraber via mailing address: 531 South Spring Street, Burlington Nc 27215.